100Plus Review for Telehealth CEOs: Simplified Remote Patient Monitoring Kits for SMB Practices
Introduction: Why RPM Is No Longer Optional
Telehealth growth is moving beyond transactional video visits. Payers, boards, and investors now demand:
- Proof of outcomes (blood pressure lowered, diabetes managed).
- Recurring revenue models (subscriptions, chronic care).
- Differentiation (continuous engagement vs one-off consults).
👉 100Plus is an RPM platform designed for small-to-mid-sized practices that want to add chronic care programs quickly. Unlike Validic (API-first) or Optimize Health (mid-market turnkey), 100Plus focuses on simplicity + speed — shipping devices, providing dashboards, and even helping with reimbursement support.
Section 1: What Is 100Plus?
- Overview: A Remote Patient Monitoring solution with FDA-cleared devices, software dashboards, and patient engagement tools.
- Target Market: Small telehealth practices, independent clinics, clinician-led startups.
- Differentiator: Ease of deployment — little to no IT lift, designed for non-technical practices.
Section 2: Compliance Check
- HIPAA: ✅ Yes, with BAA.
- FDA: Devices FDA-cleared (BP cuffs, glucose monitors, scales).
- CMS: Designed to support RPM CPT billing.
CEO takeaway: Checks compliance boxes for SMB practices; less credible for enterprise PE diligence.
Section 3: Strengths
- Simplicity
- Plug-and-play setup.
- Minimal training for staff.
- Turnkey Device Delivery
- Ships FDA-cleared devices directly to patients.
- No inventory management required.
- Revenue Enablement
- Built-in workflows for CMS reimbursement.
- Helps providers monetize chronic care programs.
- Patient Engagement Tools
- Reminders + alerts.
- Boosts adherence and visit frequency.
- Low Operational Burden
- Designed for SMB clinics with limited staff.
Section 4: Weaknesses
- Limited Device Ecosystem
- Focuses on core vitals (BP, glucose, weight).
- No advanced wearables (sleep, fertility, oncology).
- Not Enterprise-Grade
- Best for 1–50 provider orgs.
- PE/employer contracts expect Validic-scale integration.
- Basic Analytics
- Provider dashboards are functional but lack advanced reporting.
- Must add HIPAA CDPs (Freshpaint, Segment) for investor-ready insights.
Section 5: Integrations
- EHRs: Limited direct integrations; often requires HL7/FHIR middleware.
- Payments: Supports CMS reimbursement billing; basic card-on-file workflows.
- Analytics: Pair with external tools for deeper CAC/LTV visibility.
CEO Tip: Treat 100Plus as an entry RPM platform — start here, prove outcomes, then migrate to Optimize Health or Validic for scale.
Section 6: Pricing Model
- Per-patient monthly fee for device + monitoring.
- Practice subscription fees apply for software access.
- Reimbursement upside: CMS RPM codes (99453, 99454, 99457, 99458) offset costs.
Unit Economics Impact:
- Attractive for SMB clinics if reimbursement is captured.
- Fragile if churn is high or RPM billing isn’t optimized.
Section 7: Best Fit For
- Clinician-led telehealth practices.
- Small-to-mid clinics adding chronic care revenue.
- Startups needing RPM quickly without dev resources.
Not ideal for:
- PE roll-ups / enterprise exits.
- Specialty RPM beyond vitals.
- Growth-stage companies targeting national payer contracts.
Section 8: Alternatives to 100Plus
- Optimize Health → Mid-market turnkey; broader dashboards.
- Validic → Enterprise-grade API-first integration; more device coverage.
- Dexcom/Abbott APIs → For specific device categories.
👉 Related posts: [Optimize Health Review] | [Validic Review]
Section 9: CEO / Investor Lens
Fragile story:
“We don’t have RPM, but we’re considering adding it later.”
- Investors hear: weaker outcomes, fragile valuation.
Defensible story:
“We use 100Plus for RPM to prove outcomes in hypertension/diabetes. Devices ship direct to patients, and CMS reimbursement offsets costs. Data feeds into Freshpaint dashboards for board reporting.”
- Investors hear: disciplined, outcomes-focused.
Moat story:
“We used 100Plus to launch RPM fast, then migrated to Validic for expanded device integration and payer contracts. Outcomes data now powers employer partnerships.”
- Investors hear: roadmap clarity + valuation moat.
Section 10: Verdict
Strengths: Easy setup, turnkey kits, reimbursement support, low ops burden.
Weaknesses: Limited scalability, narrow device set, basic analytics.
Bottom line:
- Best for SMB telehealth practices adding RPM revenue fast.
- Not suitable as a long-term enterprise backbone — treat as a starter RPM solution.
CTA: Why RPM Is Your Outcomes Engine
100Plus helps you launch RPM quickly. But investors and payers want to see how you’ll scale.
That’s why I built the Growth Clarity Diagnostic™.
In one session, we’ll:
- Audit your RPM platform choice.
- Map reimbursement + retention risks.
- Build a roadmap from starter → enterprise RPM.
👉 [Book your Growth Clarity Diagnostic™ here.]
Because in telehealth, RPM = outcomes moat.
FAQ
Is 100Plus HIPAA compliant?
Yes, with BAA.
Does 100Plus ship devices to patients?
Yes — turnkey logistics included.
Does 100Plus support RPM reimbursement?
Yes — workflows designed for CMS RPM codes.
What’s 100Plus’s biggest strength?
Simplicity + speed of deployment.
What’s 100Plus’s biggest weakness?
Not scalable for enterprise telehealth or specialty RPM.
